Mon, March 8, 2021

Oren Livnat Maintained (VRCA) at Strong Buy with Increased Target to $24 on, Mar 8th, 2021

Oren Livnat of HC Wainwright & Co., Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Increased Target from $21 to $24 on, Mar 8th, 2021.

Oren has made no other calls on VRCA in the last 4 months.



There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Oren's Rating of Hold.



This is the rating of the analyst that currently disagrees with Oren


  • Serge Belanger of "Needham" Maintained at Strong Buy with Increased Target to $22 on, Wednesday, February 17th, 2021